Sido Muncul to acquire pharmaceutical company
Healthcare insurance in Indonesia will lead to a tremendous rise in healthcare spending

Healthcare insurance in Indonesia will lead to a tremendous rise in healthcare spending
The Jakarta Post - PT Industri Jamu dan Farmasi Sido Muncul, Indonesia’s biggest jamu (herbal medicine) producer, plans to acquire a pharmaceutical company for around Rp 150 billion (US$13.13 million).
Sido Muncul is doing due diligence on PT Berlico Mulia Farma, which has more than 80 products including as cough syrup, vitamins and indigestion pills, and may expand further in the pharmaceutical sector, Sido Muncul president director Irwan Hidayat told Reuters.
Promo Terbaru di Bareksa
Pilihan Investasi di Bareksa
Klik produk untuk lihat lebih detail.
| Produk Eksklusif | Harga/Unit | 1 Bulan | 6 Bulan | YTD | 1 Tahun | 3 Tahun | 5 Tahun |
|---|---|---|---|---|---|---|---|
Trimegah Dana Obligasi Nusantara autodebet | 1.200,15 | ||||||
STAR Stable Amanah Sukuk autodebet | 1.180,3 | - | - | ||||
Syailendra Sharia Fixed Income Fund Kelas A | 1.150,95 | - | - | ||||
Eastspring Syariah Mixed Asset Fund Kelas A | 1.033,2 | - | - | - | - | - |
Produk Belum Tersedia
Ayo daftar Bareksa SBN sekarang untuk bertransaksi ketika periode pembelian dibuka.
Produk Belum Tersedia
Ayo daftar Bareksa SBN sekarang untuk bertransaksi ketika periode pembelian dibuka.